| Typicality: | 0.335 |
| Saliency: | 0.405 |
| in preventing entry of the virus | 8 | purpose |
| for increasing hpv vaccinations | 4 | purpose |
| in earlier trials | 4 | temporal |
| approach → shown → promise | 23 |
| approach → shown → considerable promise | 5 |
| approach → be shown → promise | 5 |
| approach → shown → some promise | 4 |
| negative | neutral | positive |
| 0.058 | 0.244 | 0.698 |
| Raw frequency | 37 |
| Normalized frequency | 0.405 |
| Modifier score | 0.500 |
| Perplexity | 64.836 |